Charles River: T. Rowe Price reports 6.3% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Charles River Laboratories International, Inc. (CRL) was the subject of a Schedule 13G in which T. Rowe Price Associates, Inc. reported 3,010,619 shares, or 6.3% of the class, as beneficially owned as of September 30, 2026. It reported sole voting power over 2,768,367 shares and sole dispositive power over 3,010,619 shares, with no shared voting or dispositive power. T. Rowe Price Associates stated that the filing is not an admission of beneficial ownership and expressly denied such ownership.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.